SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (540)11/27/1999 10:09:00 PM
From: Arthur Radley  Read Replies (1) | Respond to of 626
 
Some TA on TTP from a few days ago. Don't know anything about this company and writer as to their track record. Only thing that can be said is that someone is looking at TTP and in this case he was right...it hit a new high.
"Stock of the Hour Nov 24 1999 8:19AM CST Archives...


Titan Pharmaceuticals Could Test New Highs Soon
by: Theo Spradlin

Titan Pharmaceuticals {TTP} reached a new six week high at $13 yesterday. The stock traded 1.5 times its average volume yesterday and gained almost 10 percent to break out of a short-term range between $11 3/4 and $11 3/16. TTP has climbed from a base at $7 in mid October to yesterday's close at $12 11/16 for a six week gain of 45 percent. The stock has seen elevated volume in the last nine trading days as its new uptrend intensified in its approach to new fifty-two week high territory.

6-Month Chart of TTP with 10-Day Moving Average Line

Yesterday's action represented a 10-day moving average line breakout for the stock - strong technical indication of short term upside momentum. Watch TTP for a break to new high territory soon. The stock could be considered overbought in the short term with a positive divergence from the 10-day moving average line of 13 percent and a 14-day Wilder RSI reading of 71.4, but there may be some continued upside potential before a pullback as the stock is coming out of a four day consolidation.





To: Miljenko Zuanic who wrote (540)11/29/1999 6:00:00 PM
From: Arthur Radley  Read Replies (1) | Respond to of 626
 
A nice "plug" for TTP today and comes from respected analyst and brokerage house..It appears this hit after the market closed today. cbs.marketwatch.com



To: Miljenko Zuanic who wrote (540)12/7/1999 4:23:00 PM
From: RCMac  Read Replies (1) | Respond to of 626
 
Potential further market expansion for Zomaril and other atypical anti-psychotics? An article in today's NYTimes describes the experimental efforts to treat those with early signs of Schizophrenia with Zyprexa and Risperdal. "Doctors Try a Bold Move Against Schizophrenia." Here is the link (requires free registration):
nytimes.com